⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
LLY News
Eli Lilly & Co.
China RNA Delivery Technologies Market by RNA Type, Platform, Application, End User, and Company Size, Forecast to 2035 | 18.8% CAGR Driven by LNP and mRNA Expansion
globenewswire.com
ARWR
MRNA
BNTX
ABBV
LULU
EL
LLY
CAN
Global Liver Cancer Diagnostics Market to Observe Impressive Growth at a CAGR of ~9% by 2034 | DelveInsight
globenewswire.com
LLY
MRK
GSK
BMY
AZN
PFE
NVO
REGN
RDHL
AGIO
INCY
CRBP
BMRN
VKTX
RIGL
DTIL
CRDF
BIIB
ALKS
EXAS
CLDX
SRPT
TGTX
ALNY
CHKP
TAK
HHS
SERV
GILD
HRMY
IONS
BH
FORM
JNJ
GEN
ABBV
AMGN
CRSP
CHRD
ADPT
IMUX
ALGN
EXEL
VRTX
AI Drug Discovery Forecasts Vary Widely as Sector Shifts to Deployment
prnewswire.com
ABCL
HYFT
TEM
LLY
MU
TWST
Talawar Therapeutics Appoints Industry Veterans Mittie Doyle, MD, and Susannah Gray to Board of Directors
prnewswire.com
CRVS
SANA
LLY
MRVI
FDMT
ANAB
ZYME
Lilly's oral GLP-1, Foundayo (orforglipron), was associated with significant reductions in predicted long-term risk of type 2 diabetes and cardiovascular disease
prnewswire.com
LLY
Atherosclerotic Cardiovascular Disease (ASCVD) Market Insights, Epidemiology, and Forecast - 2036 | 7MM Market to Reach USD 40 Billion as Precision Therapies Reshape Growth
globenewswire.com
AMGN
ARWR
NVS
ALNY
SNY
REGN
ESPR
JNJ
AZN
AMRN
MRK
LLY
BMY
ON
NVO
Global Lightweight Materials Market Size, Share, Trends, and Forecast, 2026-2031 | EV and Aerospace Demand to Drive 8.72% CAGR, Reaching $354.33 Billion
globenewswire.com
AA
AL
F
PCAR
GD
BA
LMT
RTX
NOC
HXL
AVAV
ADI
TXN
NVDA
AMD
INTC
MSFT
AMZN
GOOGL
IBM
GE
CAT
DE
MMM
DD
ALGN
XRAY
MRNA
PFE
JNJ
BIIB
GILD
REGN
VRTX
AMGN
BMY
ABBV
LLY
TSLA
NIO
RIVN
LCID
GM
STLA
HMC
TM
VWAGY
XPEV
LI
BYDDF
CHPT
PLUG
FCEL
SPWR
ENPH
SEDG
NEE
EXC
BEP
IRTC
RCL
CCL
NCLH
HAL
SLB
DV
BNTX
CRSP
EDIT
NTLA
XOM
CVX
COP
SBLK
ZIM
GNK
TECK
RIO
BHP
VALE
NEM
FCX
AVNT
NNDM
SSYS
CRON
TLRY
ACB
CGC
PYPL
COIN
BITF
MARA
RIOT
CLSK
PLTR
SNOW
CRWD
PANW
SMCI
EXAS
TDOC
CI
UNH
CVS
QCOM
NXPI
ON
AEHR
AMAT
LRCX
KLAC
MU
WDC
Global Drug Discovery Market (2026-2031) - AI-Driven Target Identification Accelerates Growth
globenewswire.com
NVDA
LLY
CHAI
TMO
ABBV
AMGN
AZN
BDX
BMY
CRL
JNJ
MRK
NVS
PFE
REGN
SNY
VRTX
Lilly's oral GLP-1, Foundayo (orforglipron), demonstrated cardiovascular safety alongside sustained A1C reduction and weight loss in its largest and longest type 2 diabetes study
prnewswire.com
LLY
Substance Use Disorder (SUD) Drug Pipeline Analysis Report 2026 | 100+ Drug Candidates, Phase II Dominance, and Long-Acting Therapies Signal Strategic Investment Opportunities
globenewswire.com
LLY
BG
ALKS
ALT